Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Fetomaternal Bleeding and Neonatal Hematocrit following Cesarean Delivery: Routine versus Transplacental Transection.

Gregory E, Towers CV, van Nes J, Shumard K, Fortner KB, Weitz B.

AJP Rep. 2019 Jul;9(3):e298-e301. doi: 10.1055/s-0039-1697654. Epub 2019 Sep 19.

2.

A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.

van Groningen T, Akogul N, Westerhout EM, Chan A, Hasselt NE, Zwijnenburg DA, Broekmans M, Stroeken P, Haneveld F, Hooijer GKJ, Savci-Heijink CD, Lakeman A, Volckmann R, van Sluis P, Valentijn LJ, Koster J, Versteeg R, van Nes J.

Nat Commun. 2019 Apr 4;10(1):1530. doi: 10.1038/s41467-019-09470-w.

3.

Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients.

Verly IRN, Leen R, Meinsma JR, Hooijer GKJ, Savci-Heijink CD, van Nes J, Broekmans M, Wanders RJA, van Kuilenburg ABP, Tytgat GAM.

Eur J Cancer. 2019 Apr;111:21-29. doi: 10.1016/j.ejca.2019.01.014. Epub 2019 Feb 22.

PMID:
30798085
4.

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.

Decaesteker B, Denecker G, Van Neste C, Dolman EM, Van Loocke W, Gartlgruber M, Nunes C, De Vloed F, Depuydt P, Verboom K, Rombaut D, Loontiens S, De Wyn J, Kholosy WM, Koopmans B, Essing AHW, Herrmann C, Dreidax D, Durinck K, Deforce D, Van Nieuwerburgh F, Henssen A, Versteeg R, Boeva V, Schleiermacher G, van Nes J, Mestdagh P, Vanhauwaert S, Schulte JH, Westermann F, Molenaar JJ, De Preter K, Speleman F.

Nat Commun. 2018 Nov 19;9(1):4866. doi: 10.1038/s41467-018-06699-9.

5.

Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.

Jeene PM, de Vries KC, van Nes JGH, Kwakman JJM, Wester G, Rozema T, Braam PM, Zindler JD, Koper P, Nuyttens JJ, Vos-Westerman HA, Schmeets I, Niël CGHJ, Hutschemaekers S, van der Linden YM, Verhoeff JJC, Stalpers LJA.

Acta Oncol. 2018 May;57(5):637-643. doi: 10.1080/0284186X.2017.1418534. Epub 2017 Dec 23.

PMID:
29276848
6.

Preoperative cesarean delivery intravenous acetaminophen treatment for postoperative pain control: a randomized double-blinded placebo control trial.

Towers CV, Shelton S, van Nes J, Gregory E, Liske E, Smalley A, Mobley E, Faircloth B, Fortner KB.

Am J Obstet Gynecol. 2018 Mar;218(3):353.e1-353.e4. doi: 10.1016/j.ajog.2017.12.203. Epub 2017 Dec 21.

PMID:
29274831
7.

Neuroblastoma is composed of two super-enhancer-associated differentiation states.

van Groningen T, Koster J, Valentijn LJ, Zwijnenburg DA, Akogul N, Hasselt NE, Broekmans M, Haneveld F, Nowakowska NE, Bras J, van Noesel CJM, Jongejan A, van Kampen AH, Koster L, Baas F, van Dijk-Kerkhoven L, Huizer-Smit M, Lecca MC, Chan A, Lakeman A, Molenaar P, Volckmann R, Westerhout EM, Hamdi M, van Sluis PG, Ebus ME, Molenaar JJ, Tytgat GA, Westerman BA, van Nes J, Versteeg R.

Nat Genet. 2017 Aug;49(8):1261-1266. doi: 10.1038/ng.3899. Epub 2017 Jun 26.

PMID:
28650485
8.

Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.

van Nes JG, Beex LV, Seynaeve C, Putter H, Sramek A, Lardenoije S, Duijm-de Carpentier M, Van Rongen I, Nortier JW, Zonderland HM, van de Velde CJ.

Acta Oncol. 2015 Mar;54(3):349-60. doi: 10.3109/0284186X.2014.964809. Epub 2014 Nov 10.

PMID:
25383451
9.

A NOTCH3 transcriptional module induces cell motility in neuroblastoma.

van Nes J, Chan A, van Groningen T, van Sluis P, Koster J, Versteeg R.

Clin Cancer Res. 2013 Jul 1;19(13):3485-94. doi: 10.1158/1078-0432.CCR-12-3021. Epub 2013 May 6.

10.

Expression of cell adhesion molecules and prognosis in breast cancer.

Saadatmand S, de Kruijf EM, Sajet A, Dekker-Ensink NG, van Nes JG, Putter H, Smit VT, van de Velde CJ, Liefers GJ, Kuppen PJ.

Br J Surg. 2013 Jan;100(2):252-60. doi: 10.1002/bjs.8980. Epub 2012 Nov 22.

PMID:
23175431
11.

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.

Valentijn LJ, Koster J, Haneveld F, Aissa RA, van Sluis P, Broekmans ME, Molenaar JJ, van Nes J, Versteeg R.

Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19190-5. doi: 10.1073/pnas.1208215109. Epub 2012 Oct 22.

12.

LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.

Molenaar JJ, Domingo-Fernández R, Ebus ME, Lindner S, Koster J, Drabek K, Mestdagh P, van Sluis P, Valentijn LJ, van Nes J, Broekmans M, Haneveld F, Volckmann R, Bray I, Heukamp L, Sprüssel A, Thor T, Kieckbusch K, Klein-Hitpass L, Fischer M, Vandesompele J, Schramm A, van Noesel MM, Varesio L, Speleman F, Eggert A, Stallings RL, Caron HN, Versteeg R, Schulte JH.

Nat Genet. 2012 Nov;44(11):1199-206. doi: 10.1038/ng.2436. Epub 2012 Oct 7.

PMID:
23042116
13.

Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis.

van de Water W, Fontein DB, van Nes JG, Bartlett JM, Hille ET, Putter H, Robson T, Liefers GJ, Roumen RM, Seynaeve C, Dirix LY, Paridaens R, Kranenbarg EM, Nortier JW, van de Velde CJ.

Eur J Cancer. 2013 Jan;49(2):297-304. doi: 10.1016/j.ejca.2012.07.026. Epub 2012 Sep 3.

14.

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study.

van Hoesel AQ, van de Velde CJ, Kuppen PJ, Liefers GJ, Putter H, Sato Y, Elashoff DA, Turner RR, Shamonki JM, de Kruijf EM, van Nes JG, Giuliano AE, Hoon DS.

Breast Cancer Res Treat. 2012 Aug;134(3):1103-14. doi: 10.1007/s10549-012-2038-0. Epub 2012 Apr 5.

PMID:
22476853
15.

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.

van Nes JG, Fontein DB, Hille ET, Voskuil DW, van Leeuwen FE, de Haes JC, Putter H, Seynaeve C, Nortier JW, van de Velde CJ.

Breast Cancer Res Treat. 2012 Jul;134(1):267-76. doi: 10.1007/s10549-012-2028-2. Epub 2012 Mar 28.

16.

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, Schild L, Molenaar P, Stroeken P, van Noesel MM, Ora I, Santo EE, Caron HN, Westerhout EM, Versteeg R.

Nature. 2012 Feb 22;483(7391):589-93. doi: 10.1038/nature10910.

PMID:
22367537
17.

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.

de Kruijf EM, Sajet A, van Nes JG, Putter H, Smit VT, Eagle RA, Jafferji I, Trowsdale J, Liefers GJ, van de Velde CJ, Kuppen PJ.

BMC Cancer. 2012 Jan 18;12:24. doi: 10.1186/1471-2407-12-24.

18.

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.

van Nes JG, de Kruijf EM, Putter H, Faratian D, Munro A, Campbell F, Smit VT, Liefers GJ, Kuppen PJ, van de Velde CJ, Bartlett JM.

Breast Cancer Res Treat. 2012 May;133(1):49-59. doi: 10.1007/s10549-011-1684-y. Epub 2011 Jul 28.

PMID:
21796367
19.

Patients' needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner.

van Hezewijk M, Ranke GM, van Nes JG, Stiggelbout AM, de Bock GH, van de Velde CJ.

Eur J Surg Oncol. 2011 Sep;37(9):765-73. doi: 10.1016/j.ejso.2011.06.007. Epub 2011 Jul 20.

PMID:
21764242
20.

Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer.

van Hoesel AQ, van de Velde CJ, Kuppen PJ, Putter H, de Kruijf EM, van Nes JG, Giuliano AE, Hoon DS.

Breast Cancer Res Treat. 2012 Feb;131(3):859-69. doi: 10.1007/s10549-011-1485-3. Epub 2011 Apr 11.

PMID:
21479925
21.

Fire in labor and delivery: simulation case scenario.

Berendzen JA, van Nes JB, Howard BC, Zite NB.

Simul Healthc. 2011 Feb;6(1):55-61. doi: 10.1097/SIH.0b013e318201351b. No abstract available.

PMID:
21330851
22.

The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies.

Hadji P, Asmar L, van Nes JG, Menschik T, Hasenburg A, Kuck J, Nortier JW, van de Velde CJ, Jones SE, Ziller M.

J Cancer Res Clin Oncol. 2011 Jun;137(6):1015-25. doi: 10.1007/s00432-010-0964-y. Epub 2010 Dec 18.

PMID:
21170551
23.

HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.

de Kruijf EM, Sajet A, van Nes JG, Natanov R, Putter H, Smit VT, Liefers GJ, van den Elsen PJ, van de Velde CJ, Kuppen PJ.

J Immunol. 2010 Dec 15;185(12):7452-9. doi: 10.4049/jimmunol.1002629. Epub 2010 Nov 5.

24.

Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.

van Nes JG, Putter H, van Hezewijk M, Hille ET, Bartelink H, Collette L, van de Velde CJ; EORTC Breast Cancer Group.

Eur J Surg Oncol. 2010 Jul;36(7):617-24. doi: 10.1016/j.ejso.2010.05.010. Epub 2010 Jun 16.

PMID:
20558026
25.

Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.

van Nes JG, Seynaeve C, Jones S, Markopoulos C, Putter H, van de Velde CJ; Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trialists, Hasenburg A, Rea DW, Vannetzel JM, Dirix L, Hozumi Y, Kerin MJ, Kieback DG, Meershoek-Klein Kranenbarg WM, Hille ET, Nortier JW.

Br J Surg. 2010 May;97(5):671-9. doi: 10.1002/bjs.6962.

PMID:
20393978
26.

Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.

de Kruijf EM, van Nes JG, van de Velde CJ, Putter H, Smit VT, Liefers GJ, Kuppen PJ, Tollenaar RA, Mesker WE.

Breast Cancer Res Treat. 2011 Feb;125(3):687-96. doi: 10.1007/s10549-010-0855-6. Epub 2010 Apr 2.

PMID:
20361254
27.

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients.

van Nes JG, de Kruijf EM, Faratian D, van de Velde CJ, Putter H, Falconer C, Smit VT, Kay C, van de Vijver MJ, Kuppen PJ, Bartlett JM.

Breast Cancer Res Treat. 2011 Feb;125(3):671-85. doi: 10.1007/s10549-010-0854-7. Epub 2010 Apr 1.

PMID:
20358279
28.

Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients.

Voskuil DW, van Nes JG, Junggeburt JM, van de Velde CJ, van Leeuwen FE, de Haes JC.

Ann Oncol. 2010 Oct;21(10):2094-101. doi: 10.1093/annonc/mdq151. Epub 2010 Mar 31.

PMID:
20357033
29.

The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.

de Kruijf EM, van Nes JG, Sajet A, Tummers QR, Putter H, Osanto S, Speetjens FM, Smit VT, Liefers GJ, van de Velde CJ, Kuppen PJ.

Clin Cancer Res. 2010 Feb 15;16(4):1272-80. doi: 10.1158/1078-0432.CCR-09-1844. Epub 2010 Feb 9.

30.

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.

van de Velde CJ, Verma S, van Nes JG, Masterman C, Pritchard KI.

Cancer Treat Rev. 2010 Feb;36(1):54-62. doi: 10.1016/j.ctrv.2009.10.003. Epub 2009 Nov 26. Review.

PMID:
19944537
31.

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.

van Nes JG, Seynaeve C, Maartense E, Roumen RM, de Jong RS, Beex LV, Meershoek-Klein Kranenbarg WM, Putter H, Nortier JW, van de Velde CJ; Cooperating investigators of the Dutch TEAM trial.

Ann Oncol. 2010 May;21(5):974-82. doi: 10.1093/annonc/mdp419. Epub 2009 Oct 29.

PMID:
19875752
32.

Cdx and Hox genes differentially regulate posterior axial growth in mammalian embryos.

Young T, Rowland JE, van de Ven C, Bialecka M, Novoa A, Carapuco M, van Nes J, de Graaff W, Duluc I, Freund JN, Beck F, Mallo M, Deschamps J.

Dev Cell. 2009 Oct;17(4):516-26. doi: 10.1016/j.devcel.2009.08.010.

33.

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients.

van Nes JG, Smit VT, Putter H, Kuppen PJ, Kim SJ, Daito M, Ding J, Shibayama M, Numada S, Gohda K, Matsushima T, Ishihara H, Noguchi S, van de Velde CJ.

Br J Cancer. 2009 Feb 10;100(3):494-500. doi: 10.1038/sj.bjc.6604870. Epub 2009 Jan 20.

34.

[The advantages of preoperative systemic therapy in breast cancer].

Mieog JS, van Nes JG, van de Velde CJ.

Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2501-6. Review. Dutch.

PMID:
19055256
35.

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.

van Nes JG, Putter H, Julien JP, Tubiana-Hulin M, van de Vijver M, Bogaerts J, de Vos M, van de Velde CJ; Cooperating Investigators of the EORTC.

Breast Cancer Res Treat. 2009 May;115(1):101-13. doi: 10.1007/s10549-008-0050-1. Epub 2008 May 18.

PMID:
18484198
36.

The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.

van Nes JG, van de Velde CJ.

Breast. 2006 Dec;15 Suppl 2:S3-10. Review. Erratum in: Breast. 2008 Apr;17(2):213.

PMID:
17382859
37.

[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].

van Nes JG, Seynaeve C, van de Velde CJ, Nortier JW.

Ned Tijdschr Geneeskd. 2006 Dec 30;150(52):2863-9. Review. Dutch.

PMID:
17319217
38.

[Cerebellar cortical degeneration in an American Staffordshire terrier].

Buijtels JJ, Kroeze EJ, Voorhout G, Schellens CJ, van Nes JJ.

Tijdschr Diergeneeskd. 2006 Jul 15-Aug 1;131(14-15):518-22. Dutch.

PMID:
16916197
39.

[Acute sialoadenitis of the parotid gland].

van Nes JG, de Jong SC, Vissink A.

Ned Tijdschr Tandheelkd. 2006 Mar;113(3):116-8. Dutch.

PMID:
16566403
40.

The Cdx4 mutation affects axial development and reveals an essential role of Cdx genes in the ontogenesis of the placental labyrinth in mice.

van Nes J, de Graaff W, Lebrin F, Gerhard M, Beck F, Deschamps J.

Development. 2006 Feb;133(3):419-28. Epub 2006 Jan 5.

41.

[The 4th large meta-analysis of all trials of the treatment of operable breast cancer: increased survival after a longer follow-up].

van Nes JG, Nortier WR, van de Velde CJ.

Ned Tijdschr Geneeskd. 2005 Sep 3;149(36):1978-80. Dutch.

PMID:
16171107
42.

[The multidisciplinary breast cancer care team: promoting better care].

van Nes JG, van de Velde CJ.

Ned Tijdschr Geneeskd. 2005 Aug 27;149(35):1929-31. Dutch.

PMID:
16159029
43.

Endoscopic aneurysm sac fenestration as a treatment option for growing aneurysms due to type II endoleak or endotension.

van Nes JG, Hendriks JM, Tseng LN, van Dijk LC, van Sambeek MR.

J Endovasc Ther. 2005 Aug;12(4):430-4.

PMID:
16048374
44.

Developmental regulation of the Hox genes during axial morphogenesis in the mouse.

Deschamps J, van Nes J.

Development. 2005 Jul;132(13):2931-42. Review.

45.

[Diagnostic image (236). A woman with acute unilateral swelling of the face].

van Nes JG, de Jong SC.

Ned Tijdschr Geneeskd. 2005 Apr 16;149(16):877. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2005 Jul 23;149(30):1716.

PMID:
15868992
46.

Effect of acetic acid consumption on clinical laboratory values in the dog.

Naoum H, Van Nes JJ, Kappert HJ, Beynen AC.

J Anim Physiol Anim Nutr (Berl). 2002 Apr;86(3-4):105-10.

PMID:
11972679
47.

Cerebellar cortical abiotrophy in two Portuguese Podenco littermates.

van Tongern SE, van Vonderen IK, van Nes JJ, van den Ingh TS.

Vet Q. 2000 Jul;22(3):172-4.

PMID:
10952450
48.

Fibrocartilaginous embolism of the spinal cord (FCE) in juvenile Irish Wolfhounds.

Junker K, van den Ingh TS, Bossard MM, van Nes JJ.

Vet Q. 2000 Jul;22(3):154-6.

PMID:
10952446
49.

[Geriatric peripheral vestibular ataxia].

van Nes JJ.

Tijdschr Diergeneeskd. 2000 Jul 1;125(13):431-2. Dutch. No abstract available.

PMID:
10916840
50.

[Accidental poisoning by commercial cat and dog food].

Beynen AC, van Nes JJ.

Tijdschr Diergeneeskd. 2000 Apr 1;125(7):227-8. Dutch. No abstract available.

PMID:
10896615

Supplemental Content

Loading ...
Support Center